TWO SIGMA ADVISERS, LP - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2022$23,000
+43.8%
14,100
-31.2%
0.00%
Q2 2022$16,000
-63.6%
20,500
-16.7%
0.00%
Q1 2022$44,000
-61.1%
24,600
-62.8%
0.00%
Q4 2021$113,000
-25.7%
66,100
-10.6%
0.00%
Q3 2021$152,000
+15.2%
73,900
+29.0%
0.00%
Q2 2021$132,000
-68.6%
57,300
-62.0%
0.00%
-100.0%
Q1 2021$421,000
-36.3%
150,900
-34.9%
0.00%
-50.0%
Q4 2020$661,000
-26.8%
231,800
-46.1%
0.00%
-33.3%
Q3 2020$903,000
-51.3%
429,800
+5.4%
0.00%
-40.0%
Q2 2020$1,856,000
-34.9%
407,900
+16.8%
0.01%
-54.5%
Q1 2020$2,853,000
-47.7%
349,200
+17.3%
0.01%
-15.4%
Q4 2019$5,459,000
+1564.3%
297,800
+906.1%
0.01%
+1200.0%
Q3 2019$328,000
+45.8%
29,600
+33.9%
0.00%0.0%
Q2 2019$225,000
+221.4%
22,100
+85.7%
0.00%
Q1 2019$70,000
-31.4%
11,900
-16.8%
0.00%
Q4 2018$102,000
-40.4%
14,300
-40.7%
0.00%
Q3 2018$171,000
-40.4%
24,100
-57.8%
0.00%
-100.0%
Q2 2018$287,000
+37.3%
57,100
+200.5%
0.00%0.0%
Q1 2018$209,00019,0000.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders